Publication | Closed Access

Metronomic capecitabine as adjuvant therapy in locoregionally advanced nasopharyngeal carcinoma: a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial

OncologyAdvanced Nasopharyngeal CarcinomaMetronomic TherapyNasopharyngeal CancerPathologyMetronomic ChemotherapyCancer TreatmentMedicineRadiation OncologyCancer ResearchPhase 3Metronomic Capecitabine